Frontiers in Drug Discovery

Volume: 2

Monoamine Oxidase-A: A Valid Target for the Management of Depression

Author(s): Bijo Mathew and Jerad Suresh

Pp: 126-134 (9)

DOI: 10.2174/9781681084732117020008

* (Excluding Mailing and Handling)


Monoamine oxidase enzyme has been developed as a valid target for the treatment of depression. The development of selective and reversible type of monoamine oxidase-A inhibitors still remains a challenge to medicinal chemists pursuing the research towards the search of innovative chemotypes for the management of depressive states. The present chapter focuses on the history of MAO-A inhibitors, structure and biochemistry of MAO-A. It also covers challenges involved in the drug development of MAO-A inhibitors.

Keywords: Adrenaline, Chees effect, Depression, FAD/Dopamine, Inhibitor binding cavity, MAO-A, MAO-B, Moclobemide, Tranylcypromine.

Related Journals
Related Books
© 2024 Bentham Science Publishers | Privacy Policy